Literature DB >> 8600382

Erythropoietin abuse in athletes.

R Gareau, M Audran, R D Baynes, C H Flowers, A Duvallet, L Senécal, G R Brisson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8600382     DOI： 10.1038/380113a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  The future of doping control in athletes. Issues related to blood sampling.

Authors:  K I Birkeland; P Hemmersbach
Journal:  Sports Med       Date:  1999-07       Impact factor: 11.136

2.  Erythropoietin and blood doping.

Authors:  N Robinson; S Giraud; C Saudan; N Baume; L Avois; P Mangin; M Saugy
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

3.  Comparison of a direct and indirect population pharmacodynamic model: application to recombinant human erythropoietin in athletes.

Authors:  F Bressolle; M Audran; R Gareau; T N Pham; R Gomeni
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

Review 4.  Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.

Authors:  Randall L Wilber
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

5.  Effects of exercise on soluble transferrin receptor and other variables of the iron status.

Authors:  Y Olaf Schumacher; A Schmid; D König; A Berg
Journal:  Br J Sports Med       Date:  2002-06       Impact factor: 13.800

Review 6.  Animal and plant cell technology: a critical evaluation of the technology/society interface.

Authors:  R E Spier
Journal:  J Biotechnol       Date:  1998-10-27       Impact factor: 3.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.